Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HEALTHEQUITY, INC.
Report date September 20, 2021 · Filed September 21, 2021
Section 16 reporting ended · disclosed 2021-09-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 91,052 |
Ending reported balance
After 2021-09-20 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2021-09-20 · Exercise / conversion · Acquired 10,000 · Balance 97,052 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. Row 2 · 2021-09-20 · Sale · Disposed 5,665 · Balance 91,387 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.53 to $62.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4. Row 3 · 2021-09-20 · Sale · Disposed 335 · Balance 91,052 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.00 · Expires 2024-07-30 | Direct | 20,000 |
Reported balance
After 2021-09-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-09-20 · Exercise / conversion · Disposed 10,000 · Balance 20,000 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020. F3: The option is immediately exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $25.39 · Expires 2025-03-26 | Direct | 25,000 |
Reported balance
Holding disclosure · report date 2021-09-20 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 25,000 F3: The option is immediately exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.28 · Expires 2027-03-27 | Direct | 19,897 |
Reported balance
Holding disclosure · report date 2021-09-20 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 19,897 F3: The option is immediately exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.72 · Expires 2028-03-27 | Direct | 14,228 |
Reported balance
Holding disclosure · report date 2021-09-20 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 14,228 F4: The option is exercisable as to 10,671 shares. The remaining 3,557 options vest on March 27, 2022. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $73.61 · Expires 2029-03-26 | Direct | 15,337 |
Reported balance
Holding disclosure · report date 2021-09-20 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 15,337 F5: The option is exercisable as to 7,669 shares. The remaining options vest as to 3,834 shares on each of March 27, 2022 and 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.53 to $62.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4.
F3: The option is immediately exercisable.
F4: The option is exercisable as to 10,671 shares. The remaining 3,557 options vest on March 27, 2022.
F5: The option is exercisable as to 7,669 shares. The remaining options vest as to 3,834 shares on each of March 27, 2022 and 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2019 Filed May 22, 2019 16:15 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 1,900 | $67.73 | $128,683.96 |
DisclosureSEC source: 0001179110-19-006483 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,100 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.18 to $68.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) and (3) of this Form 4. Read SEC document |
| April 22, 2019 Filed Apr 24, 2019 16:57 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 3,500 | $66.46 | $232,617.35 |
DisclosureSEC source: 0001179110-19-005142 · edgar.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.95 to $66.85, inclusive. Read SEC document |
| April 22, 2019 Filed Apr 24, 2019 16:57 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 500 | $65.00 | $32,500.00 |
DisclosureSEC source: 0001179110-19-005142 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.62 to $65.49, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4. Read SEC document |
| March 26, 2019 Filed Mar 28, 2019 17:33 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantStock Option (right to buy) · Derivative | 15,337 | $0.00 Strike: $73.61 | $0.00 |
DisclosureSEC source: 0001179110-19-004375 · edgar.xml · derivative · entry 6 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,337 Underlying: Common Stock · 15,337 shares Expires 2029-03-26 F5 · derivative.exercise_date: The Option vests as to 3,835 shares on March 27, 2020. The remaining options vest as to 3,834 shares on each of March 27, 2021, 2022 and 2023. Read SEC document |
| March 26, 2019 Filed Mar 28, 2019 17:33 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001179110-19-004375 · edgar.xml · derivative · entry 4 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 40,000 shares Expires 2024-07-30 F3 · shares: On July 30, 2014, the reporting person was granted an option to purchase 100,000 shares of common stock. The option vests in annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending January 31, 2016 (10%), 2017 (20%), 2018 (30%) and 2019 (40%). The performance criteria for 2019 were met, resulting in the vesting of the option as to 40,000 shares. F2 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 17:21 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 4,000 | $84.60 | $338,386.80 |
DisclosureSEC source: 0001179110-19-004192 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.27 to $84.98, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4. Read SEC document |
| February 20, 2019 Filed Feb 21, 2019 17:56 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 4,000 | $77.87 | $311,478.40 |
DisclosureSEC source: 0001179110-19-002266 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.37 to $78.29, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) of this Form 4. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 12:03 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 1,200 | $61.74 | $74,089.68 |
DisclosureSEC source: 0001179110-19-000890 · edgar.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.27 to $62.14, inclusive. Read SEC document |
| January 22, 2019 Filed Jan 24, 2019 12:03 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 2,800 | $60.41 | $169,161.44 |
DisclosureSEC source: 0001179110-19-000890 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.12 to $61.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) and (3) of this Form 4. Read SEC document |
| December 20, 2018 Filed Dec 26, 2018 13:15 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 4,000 | $60.28 | $241,111.20 |
DisclosureSEC source: 0001179110-18-014250 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.85 to $60.73, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 of this Form 4. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 17:57 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 195 | $78.42 | $15,292.50 |
DisclosureSEC source: 0001179110-18-013114 · edgar.xml · nonDerivative · entry 5 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.35 to $78.50, inclusive. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 17:57 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 2,105 | $77.84 | $163,857.41 |
DisclosureSEC source: 0001179110-18-013114 · edgar.xml · nonDerivative · entry 4 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,195 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.33 to $78.10, inclusive. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 17:57 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 500 | $76.84 | $38,421.00 |
DisclosureSEC source: 0001179110-18-013114 · edgar.xml · nonDerivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,300 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.26 to $77.18, inclusive. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 17:57 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 700 | $75.48 | $52,839.01 |
DisclosureSEC source: 0001179110-18-013114 · edgar.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,800 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.06 to $75.95, inclusive. Read SEC document |
| November 20, 2018 Filed Nov 21, 2018 17:57 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 500 | $74.44 | $37,219.00 |
DisclosureSEC source: 0001179110-18-013114 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.01 to $74.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2, 3, 4, 5) and (6) to this Form 4. Read SEC document |
| October 22, 2018 Filed Oct 23, 2018 17:52 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 2,500 | $87.28 | $218,203.50 |
DisclosureSEC source: 0001179110-18-012312 · edgar.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.09 to $87.46, inclusive. Read SEC document |
| October 22, 2018 Filed Oct 23, 2018 17:52 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 1,500 | $86.56 | $129,839.55 |
DisclosureSEC source: 0001179110-18-012312 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.96 to $86.87, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| September 20, 2018 Filed Sep 21, 2018 17:10 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 2,100 | $93.34 | $196,004.55 |
DisclosureSEC source: 0001179110-18-011614 · edgar.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.95 to $93.60, inclusive. Read SEC document |
| September 20, 2018 Filed Sep 21, 2018 17:10 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 1,900 | $92.48 | $175,708.01 |
DisclosureSEC source: 0001179110-18-011614 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,100 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.92 to $92.90, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 16:29 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 1,200 | $86.92 | $104,298.00 |
DisclosureSEC source: 0001179110-18-010775 · edgar.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.65 to $87.54, inclusive. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 16:29 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 2,800 | $86.14 | $241,200.96 |
DisclosureSEC source: 0001179110-18-010775 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,200 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 8, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.59 to $86.59, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| May 21, 2018 Filed May 23, 2018 17:10 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001179110-18-007429 · edgar.xml · derivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires 2021-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F3 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| May 21, 2018 Filed May 23, 2018 17:10 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 9,500 | $73.93 | $702,336.90 |
DisclosureSEC source: 0001179110-18-007429 · edgar.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,000 F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.51 to $74.18, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| May 21, 2018 Filed May 23, 2018 17:10 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 12,500 | $1.25 | $15,625.00 |
DisclosureSEC source: 0001179110-18-007429 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. Read SEC document |
| April 20, 2018 Filed Apr 23, 2018 19:45 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001179110-18-005829 · edgar.xml · derivative · entry 4 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2021-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F3 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| April 20, 2018 Filed Apr 23, 2018 19:45 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 300 | $66.06 | $19,818.00 |
DisclosureSEC source: 0001179110-18-005829 · edgar.xml · nonDerivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,000 F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. Read SEC document |
| April 20, 2018 Filed Apr 23, 2018 19:45 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 9,200 | $65.46 | $602,209.00 |
DisclosureSEC source: 0001179110-18-005829 · edgar.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,300 F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.05 to $65.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| April 20, 2018 Filed Apr 23, 2018 19:45 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 12,500 | $1.25 | $15,625.00 |
DisclosureSEC source: 0001179110-18-005829 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. Read SEC document |
| March 27, 2018 Filed Mar 29, 2018 16:34 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantStock Option (right to buy) · Derivative | 14,228 | $0.00 Strike: $61.72 | $0.00 |
DisclosureSEC source: 0001179110-18-004918 · edgar.xml · derivative · entry 6 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,228 Underlying: Common Stock · 14,228 shares Expires 2028-03-27 F5 · derivative.exercise_date: The option becomes exercisable in four equal installments of 3,557 shares on March 27, 2019, 2020, 2021, and 2022. Read SEC document |
| March 27, 2018 Filed Mar 29, 2018 16:34 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001179110-18-004918 · edgar.xml · derivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 30,000 shares Expires 2024-07-30 F2 · shares: On June 30, 2014, the reporting person was granted an option to purchase 100,000 shares of common stock. The option vests in annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending January 31, 2016 (10%), 2017 (20%), 2018 (30%) and 2019 (40%). The performance criteria for 2018 were met, resulting in the vesting of the option as to 30,000 shares. F1 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 16:28 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001179110-18-004771 · edgar.xml · derivative · entry 5 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 12,500 shares Expires 2021-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F5 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 16:28 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 6,500 | $61.50 | $399,721.40 |
DisclosureSEC source: 0001179110-18-004771 · edgar.xml · nonDerivative · entry 4 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,000 F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.20 to $61.81, inclusive. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 16:28 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 1,300 | $60.70 | $78,908.96 |
DisclosureSEC source: 0001179110-18-004771 · edgar.xml · nonDerivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,500 F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.17 to $61.11, inclusive. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 16:28 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 1,700 | $59.42 | $101,018.08 |
DisclosureSEC source: 0001179110-18-004771 · edgar.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,800 F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.11 to $60.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| March 20, 2018 Filed Mar 22, 2018 16:28 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 12,500 | $1.25 | $15,625.00 |
DisclosureSEC source: 0001179110-18-004771 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 17:30 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001179110-18-002599 · edgar.xml · derivative · entry 4 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 12,500 shares Expires 2021-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F4 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 17:30 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 172 | $56.03 | $9,636.76 |
DisclosureSEC source: 0001179110-18-002599 · edgar.xml · nonDerivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,000 F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.99 to $56.08, inclusive. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 17:30 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 9,328 | $55.18 | $514,703.18 |
DisclosureSEC source: 0001179110-18-002599 · edgar.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,172 F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.93 to $55.86, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 17:30 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 12,500 | $1.25 | $15,625.00 |
DisclosureSEC source: 0001179110-18-002599 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. Read SEC document |
| January 22, 2018 Filed Jan 23, 2018 18:44 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001179110-18-001033 · edgar.xml · derivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 12,500 shares Expires 2021-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F3 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| January 22, 2018 Filed Jan 23, 2018 18:44 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 9,500 | $48.00 | $456,014.25 |
DisclosureSEC source: 0001179110-18-001033 · edgar.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.80 to $48.29, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| January 22, 2018 Filed Jan 23, 2018 18:44 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 12,500 | $1.25 | $15,625.00 |
DisclosureSEC source: 0001179110-18-001033 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. Read SEC document |
| December 20, 2017 Filed Dec 21, 2017 17:43 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001179110-17-015798 · edgar.xml · derivative · entry 4 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 12,500 shares Expires 2021-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F4 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| December 20, 2017 Filed Dec 21, 2017 17:43 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 1,500 | $48.27 | $72,409.95 |
DisclosureSEC source: 0001179110-17-015798 · edgar.xml · nonDerivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,000 F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.25 to $48.35, inclusive. Read SEC document |
| December 20, 2017 Filed Dec 21, 2017 17:43 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 8,000 | $47.84 | $382,738.40 |
DisclosureSEC source: 0001179110-17-015798 · edgar.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,500 F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.25 to $48.23, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes(2)and(3)to this Form 4. Read SEC document |
| December 20, 2017 Filed Dec 21, 2017 17:43 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 12,500 | $1.25 | $15,625.00 |
DisclosureSEC source: 0001179110-17-015798 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 10:54 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001179110-17-014493 · edgar.xml · derivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 12,500 shares Expires 2021-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F3 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 10:54 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | SaleCommon Stock | 9,500 | $49.68 | $471,976.15 |
DisclosureSEC source: 0001179110-17-014493 · edgar.xml · nonDerivative · entry 2 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.06 to $50.34, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 10:54 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionCommon Stock | 12,500 | $1.25 | $15,625.00 |
DisclosureSEC source: 0001179110-17-014493 · edgar.xml · nonDerivative · entry 1 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. Read SEC document |
| October 20, 2017 Filed Oct 24, 2017 13:19 UTC | HEALTHEQUITY, INC. HQY · Entity 3639 | Exercise / conversionStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001140361-17-039367 · doc1.xml · derivative · entry 3 MOTT DARCY G · CIK 0001179972 · Executive VP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 12,500 shares Expires 2021-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2017. F3 · derivative.exercise_date: The option is immediately exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.